NASDAQ:GOVX
GeoVax Labs, Inc.
GeoVax Labs, Inc.'s revenue fell 37.1% in fiscal 2025 to $2.5M while operating margin fell to −869.3%. Free cash flow was −$21.5M, −863.8% of revenue.Summary generated from GeoVax Labs, Inc.'s SEC filings. Latest annual report filed Apr 15, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$2.5M
Revenue growth−37.1%
Revenue, 5-yr CAGR+6.4%
Gross marginn/a
Operating margin−869.3%
Net margin−862.3%
ROICn/a
Return on equity−483.8%
Debt / equityn/a
Free cash flow−$21.5M
FCF margin−863.8%
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 4 | 2 |
| Operating income | −19 | −14 | −27 | −25 | −22 |
| Net income | −19 | −14 | −26 | −25 | −21 |
| Free cash flow | −11 | −19 | −25 | −25 | −22 |
Recent filings
- S-1Registration statement
Sep 17, 2026 - DEF 14AProxy statement
Sep 10, 2026 - 8-KOther events
Sep 10, 2026 - 8-KNotice of delisting or listing-rule failure
Aug 28, 2026 - 8-KEntry into a material agreement
Aug 28, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 27, 2026 - 8-KResults of operations and financial condition
Jul 27, 2026 - 8-KNotice of delisting or listing-rule failure
Jul 10, 2026